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on a flat couch (FC) while others make use of an angulated breast 
board (AB). We, therefore, studied the effect of the patient 
positioning on the dose distribution in the Planning Target Volume 
(PTV) as well as on the (mean) dose to the normal structures. 
Materials and Methods: Ten patients with left-sided breast cancer 
referred for radiotherapy after breast conserving surgery were 
included in our study. All patients underwent a CT-scan on a flat 
couch as well as an angulated breast board, both in supine treatment 
position. To avoid interobserver differences, the Clinical Target 
Volume (CTV), stomach, axilla, plexus brachialis and heart were 
contoured by one observer. The lungs were contoured automatically. 
The PTV trim was defined by enlarging the CTV of the glandular breast 
tissue with 5mm in the AP, LR direction and 6mm in the CC direction, 
and was trimmed 5mm under the skin. We subsequently compared a 
3D-CRT treatment plan in the FC with the AB position. All plans had to 
meet the following criteria: 
- 97% of PTV trim is covered by the 95% isodose (V95%); 
- Maximum Heart Distance: < 1.5 cm; 
- Mean Lung Dose (as based on both lungs): < 7.5 Gy. 
We analyzed the PTVtrim volumes and the mean dose in all delineated 
normal structures in both positions. 
Results: In both positions the mean PTVtrim was 905 cm3 (282 – 1780). 
The PTVtrim was displaced to the cranial part of the patient, see 
figure 1. 
 
  
Figure 1. Patient no. 3. Axial CT-slice at the carina level of the lung: 
Left: flat couch; Right: angulated breast board. 
For PTVtrim, the heart, lungs and stomach no statistically significant 
differences were found. In all patients a significantly higher mean 
dose in the plexus brachialis and axilla was found, see table 1. 
 
Table 1. Flat Angulated p-value 
PTV-V107% (%) 2.4 0 0.08 
PTV-V110% (%) 1.1 0 0.2 
Heart-mean (Gy) 3.2 2.5 0.09 
Mean Lung Dose (Gy) 2.2 1.9 0.07 
Stomach-mean (Gy) 1.2 1.1 0.3 
Plexus Brachialis-mean (Gy) 6.9 2.5 < 0.01 
Axilla-mean (Gy) 30.1 23.4 < 0.01 
 
Conclusions: Between the two positions no differences were noted in 
PTVtrim volume or mean dose in heart, lungs and stomach. 
Furthermore, the dose in the plexus brachialis and axilla was 
increased. Since the introduction of more intensive imaging 
procedures for position verification now obligates the clinician to 
evaluate therapeutic and imaging doses in a more balanced manner. 
The aim is to keep the dose outside the treatment fields 'As Low As 
Reasonably Achievable' (ALARA). Therefore, it seems preferable in 
breast conserving radiotherapy, to use an angulated board to reduce 
the dose in the normal structures. 
   
 POSTER: RTT TRACK: TREATMENT PLANNING AND 
DOSE CALCULATION  
  
PO-0928   
Range shifter optimization in pencil beam scanning-based proton 
therapy 
F. Fellin1, G. Fava1, M. Schwarz1 
1Azienda Provinciale per i Servizi Sanitari - Agenzia Provinciale per la 
Protonterapia, Medical Physics, Trento, Italy  
 
Purpose/Objective: To test whether range shifter optimization, i.e. 
limiting the use of range shifter (RS) only to the energy layers where it 
is strictly needed, allows for high-quality isocentric treatments. 
Materials and Methods: Intensity Modulated Proton Therapy (IMPT) 
plans were performed with a commercial treatment planning system 
(XiO, Elekta, ver. 4.64.02) on four CT datasets of patients with 
different positions and dimensions of target volume: one 
mesothelioma (case 1), one left brain-chondrosarcoma (case 2) and 
two different skull base-chordoma (case 3, case 4).  
The beam model parameters were: sigma dimension range 4.6 (at 100 
MeV) - 1.7 (at 236 MeV), proton pencil beams depth range (without 
range shifter) 7.6 - 32.5 cm.  
For all CT dataset the target volumes were at least in part shallower 
than the minimum depth below which a RS is needed (7.6 cm water 
equivalent depth from patient surface).  
On every dataset, we created four PBS plans setting the fields as 
follows: 
1. RS always in the beam (i.e. for all enerGy (RBE) layers) with 
standard airgap and isocentric fields (RSAG); 
2. RS optimization (i.e. using it only when needed) with standard 
airgap and isocentric fields (RSoptAG); 
3. RS always in the beam with 5 cm airgap, non-isocentric fields 
(RSAGopt); 
4. RS optimization with 5 cm airgap, non-isocentric fields 
(RSoptAGopt). 
In all cases, we used clinically applied prescription dose and OARs 
constraints. 
All plans were performed using two field directions. 
For RSAG and RSoptAG configurations, we used one beam per field 
direction.  
For RSoptAG and RSoptAGopt, we used two beams for field direction, 
one with RS, for delivered the superficial proton pencil beams, and 
the other without, for the others. 
Results: All fields configurations complied with target volume dose 
objectives in all clinical cases.  
Concerning the OARs (Figure1), RSAG configuration is to be avoided 
because results were always the worst and sometimes the OARs 
constraints were not respected. 
RSAGopt is the most commonly used and it provides acceptable 
results, but it significantly disrupts the treatment workflow as an 
operator has to enter the treatment room at every field.  
RSoptAG configuration provided results at least good as RSAGopt and 
sometimes better especially in lesions that required the use of RS only 
for a little portion of the target volume (case 3, case 4). In addition, 
RSoptAG configuration allows to perform isocentric treatment and 
thus to avoid the an operator entering the treatment room between 
fields delivery, thus improving the workflow. 
RSoptAGopt provided always the best results in OARs and target 
coverage but in the practical clinic this treatment settings results to 
be uncomfortable like RSAGopt. 
 
  
Conclusions: Range shifter optimization is a valid alternative in IMPT 
to perform high-quality isocentric treatments for lesions that required 
the use of RS. Simply by optimizing RS, one can improve the workflow 
of a protontherapy center without any impact on the treatment 
quality. 
   
 
 
 
 
